Association between circulating angiotensin-converting enzyme and exercise-induced pulmonary haemorrhage in Thoroughbred racehorses.

This study investigates how the level of angiotensin-converting enzyme (ACE) in the blood of racehorses can indicate the risk and severity of exercise-induced pulmonary haemorrhage (EIPH), a condition that impairs their performance. The findings suggest that higher ACE activity is associated with greater haemorrhage, pointing towards its potential use as a biomarker for this condition in equine sports medicine.

Background and Purpose of the Study

• The study centres on exercise-induced pulmonary haemorrhage (EIPH), a condition that can affect the performance of racehorses. This condition is typically diagnosed with endoscopy, possibly supplemented with bronchoalveolar lavage.
• However, the researchers seek to explore novel methods to assess the risk and severity of EIPH, focusing specifically on the use of biomarkers, which could progress the field of equine sports medicine.
• To this end, the study looks at the role of the angiotensin-converting enzyme (ACE) in EIPH, with an aim to understand whether its activity level in a horse’s plasma could serve as an effective biomarker for the condition.

Study Findings

• The key finding of the research was that horses with higher degrees of haemorrhage demonstrated increased ACE activity. This correlation suggests that the level of ACE activity could indeed be a promising candidate as a biomarker for EIPH.
• Specifically, the elevated ACE activity in the plasma of racehorses with more severe EIPH indicates that they may be at a higher risk for the condition, or that their symptoms may get more severe, if untreated.

Significance and Implications

• The findings represent an important contribution to equine sports medicine, with potential real-world implications for the health and performance of racehorses.
• The activity level of ACE in plasma could be used as a simple and non-invasive method to identify horses that are at a greater risk of developing EIPH, or those that already have the condition and could potentially suffer from heightened severity.
• Lastly, this biomarker approach could act as a supplement to the currently used diagnostic procedures like endoscopy, or even an alternative for cases where invasive procedures are not preferred. This could enable early detection and intervention strategies for EIPH in racehorses, thereby improving their health and performance in races.